Published in J Am Geriatr Soc on July 01, 2007
Rejections of drug claims for nursing home residents under Medicare Part D. Health Aff (Millwood) (2008) 1.63
Nursing home residents and enrollment in Medicare Part D. J Am Geriatr Soc (2009) 1.14
Medicare part D and the nursing home setting. Gerontologist (2008) 0.93
Effect of Part D coverage restrictions for antidepressants, antipsychotics, and cholinesterase inhibitors on related nursing home resident outcomes. J Am Geriatr Soc (2014) 0.84
Alzheimer's disease: a healthcare burden of epidemic proportion. Am Health Drug Benefits (2009) 0.75
Medicare Part D: it should be all about quality ... stupid! J Am Geriatr Soc (2007) 0.75
Medicare part d and the federal employees health benefits program: a comparison of prescription drug coverage. Am Health Drug Benefits (2013) 0.75
Patients' expectations about effects of chemotherapy for advanced cancer. N Engl J Med (2012) 10.93
The Oregon experiment--effects of Medicaid on clinical outcomes. N Engl J Med (2013) 10.01
Comparative effectiveness of minimally invasive vs open radical prostatectomy. JAMA (2009) 7.25
Health care costs in the last week of life: associations with end-of-life conversations. Arch Intern Med (2009) 6.46
THE OREGON HEALTH INSURANCE EXPERIMENT: EVIDENCE FROM THE FIRST YEAR. Q J Econ (2012) 5.98
Unintended consequences of caps on Medicare drug benefits. N Engl J Med (2006) 5.67
The effect of Medicare Part D on drug and medical spending. N Engl J Med (2009) 5.55
Does reimbursement influence chemotherapy treatment for cancer patients? Health Aff (Millwood) (2006) 4.33
Utilization and outcomes of minimally invasive radical prostatectomy. J Clin Oncol (2008) 4.23
Frequency and cost of chemotherapy-related serious adverse effects in a population sample of women with breast cancer. J Natl Cancer Inst (2006) 4.01
The costs of a national health information network. Ann Intern Med (2005) 3.93
Associations between palliative chemotherapy and adult cancer patients' end of life care and place of death: prospective cohort study. BMJ (2014) 3.90
Toward a 21st-century health care system: recommendations for health care reform. Ann Intern Med (2009) 3.85
Place of death: correlations with quality of life of patients with cancer and predictors of bereaved caregivers' mental health. J Clin Oncol (2010) 3.78
Behavioral health insurance parity for federal employees. N Engl J Med (2006) 3.77
Cost sharing and adherence to tyrosine kinase inhibitors for patients with chronic myeloid leukemia. J Clin Oncol (2013) 3.70
Physician factors associated with discussions about end-of-life care. Cancer (2010) 3.54
How Medicare's payment cuts for cancer chemotherapy drugs changed patterns of treatment. Health Aff (Millwood) (2010) 3.24
Effectiveness of primary androgen-deprivation therapy for clinically localized prostate cancer. J Clin Oncol (2014) 3.17
Geographic variation in Medicare drug spending. N Engl J Med (2010) 3.04
Validation of an algorithm for categorizing the severity of hospital emergency department visits. Med Care (2010) 2.67
The association of race/ethnicity, insurance status, and socioeconomic factors with breast cancer care. Cancer (2010) 2.63
Variation in patient-sharing networks of physicians across the United States. JAMA (2012) 2.59
A population-based assessment of specialty physician involvement in cancer clinical trials. J Natl Cancer Inst (2011) 2.48
Should drug prices be negotiated under part D of Medicare? And if so, how? Health Aff (Millwood) (2008) 2.42
Medicare's bundled payment pilot for acute and postacute care: analysis and recommendations on where to begin. Health Aff (Millwood) (2011) 2.39
Geographic variation in the quality of prescribing. N Engl J Med (2010) 2.38
Medicare beneficiaries' knowledge of Part D prescription drug program benefits and responses to drug costs. JAMA (2008) 2.31
Moving beyond parity--mental health and addiction care under the ACA. N Engl J Med (2011) 2.20
Survival and changes in comorbidities after bariatric surgery. Ann Surg (2008) 2.19
An economic history of Medicare part C. Milbank Q (2011) 2.19
Immediate risk of suicide and cardiovascular death after a prostate cancer diagnosis: cohort study in the United States. J Natl Cancer Inst (2010) 2.18
Trends in mammography screening rates after publication of the 2009 US Preventive Services Task Force recommendations. Cancer (2013) 2.14
Evidence-based risk communication: a systematic review. Ann Intern Med (2014) 2.14
End-of-life care discussions among patients with advanced cancer: a cohort study. Ann Intern Med (2012) 2.08
Ensuring the fiscal sustainability of health care reform. N Engl J Med (2009) 2.08
Androgen-deprivation therapy in prostate cancer and cardiovascular risk: a science advisory from the American Heart Association, American Cancer Society, and American Urological Association: endorsed by the American Society for Radiation Oncology. CA Cancer J Clin (2010) 2.05
The effects of the coverage gap on drug spending: a closer look at Medicare Part D. Health Aff (Millwood) (2009) 2.02
Survival of older patients with cancer in the Veterans Health Administration versus fee-for-service Medicare. J Clin Oncol (2012) 2.00
Association between the Part D coverage gap and adverse health outcomes. J Am Geriatr Soc (2012) 1.99
The effect of consumer-directed health plans on the use of preventive and chronic illness services. Health Aff (Millwood) (2008) 1.97
Associations between end-of-life discussion characteristics and care received near death: a prospective cohort study. J Clin Oncol (2012) 1.95
Impact of FDA drug risk communications on health care utilization and health behaviors: a systematic review. Med Care (2012) 1.91
Incidence of second malignancies among patients treated with proton versus photon radiation. Int J Radiat Oncol Biol Phys (2013) 1.89
The role of primary care physicians in cancer care. J Gen Intern Med (2009) 1.87
A snapshot of smokers after lung and colorectal cancer diagnosis. Cancer (2012) 1.85
New Jersey's efforts to improve postpartum depression care did not change treatment patterns for women on medicaid. Health Aff (Millwood) (2011) 1.83
Physical and mental health status of older long-term cancer survivors. J Am Geriatr Soc (2005) 1.82
Explaining racial differences in prostate cancer mortality. Cancer (2012) 1.82
What does the RAND Health Insurance Experiment tell us about the impact of patient cost sharing on health outcomes? Am J Manag Care (2008) 1.81
Discussions with physicians about hospice among patients with metastatic lung cancer. Arch Intern Med (2009) 1.77
Differences in clinical trial patient attributes and outcomes according to enrollment setting. J Clin Oncol (2009) 1.74
Elapsed time in emergency medical services for patients with cardiac complaints: are some patients at greater risk for delay? Circ Cardiovasc Qual Outcomes (2009) 1.71
Is spending more always wasteful? The appropriateness of care and outcomes among colorectal cancer patients. Health Aff (Millwood) (2008) 1.70
Mapping physician networks with self-reported and administrative data. Health Serv Res (2011) 1.70
A political history of federal mental health and addiction insurance parity. Milbank Q (2010) 1.70
Trends in racial and age disparities in definitive local therapy of early-stage breast cancer. J Clin Oncol (2008) 1.69
Medical oncologists' perceptions of financial incentives in cancer care. J Clin Oncol (2012) 1.69
National Institutes of Health state-of-the-science conference statement: Enhancing use and quality of colorectal cancer screening. Ann Intern Med (2010) 1.67
The geographic distribution of physicians revisited. Health Serv Res (2005) 1.66
Factors influencing changes in employment among women with newly diagnosed breast cancer. Cancer (2009) 1.66
Androgen-deprivation therapy for nonmetastatic prostate cancer is associated with an increased risk of peripheral arterial disease and venous thromboembolism. Eur Urol (2012) 1.65
Rejections of drug claims for nursing home residents under Medicare Part D. Health Aff (Millwood) (2008) 1.63
Geographic variation in cancer-related imaging: Veterans Affairs health care system versus Medicare. Ann Intern Med (2014) 1.62
Understanding variation in primary prostate cancer treatment within the Veterans Health Administration. Urology (2012) 1.62
High-deductible health insurance plans: efforts to sharpen a blunt instrument. Health Aff (Millwood) (2009) 1.56
Physician patient-sharing networks and the cost and intensity of care in US hospitals. Med Care (2012) 1.56
Effect of electronic health records on health care costs: longitudinal comparative evidence from community practices. Ann Intern Med (2013) 1.52
Does oral antiandrogen use before leuteinizing hormone-releasing hormone therapy in patients with metastatic prostate cancer prevent clinical consequences of a testosterone flare? Urology (2009) 1.52
Intended and unintended consequences of the gabapentin off-label marketing lawsuit among patients with bipolar disorder. J Clin Psychiatry (2012) 1.48
Income, insurance, and technology: why does health spending outpace economic growth? Health Aff (Millwood) (2009) 1.44
The impact of Medicare Part D on medication adherence among older adults enrolled in Medicare-Advantage products. Med Care (2010) 1.43
The economic impacts of the tobacco settlement. J Policy Anal Manage (2002) 1.40
Aligning incentives in the treatment of depression in primary care with evidence-based practice. Psychiatr Serv (2003) 1.39
Coping with prescription drug cost sharing: knowledge, adherence, and financial burden. Health Serv Res (2008) 1.38
Implementation of Medicare Part D and nondrug medical spending for elderly adults with limited prior drug coverage. JAMA (2011) 1.36
Whom do older adults trust most to provide information about prescription drugs? Am J Geriatr Pharmacother (2009) 1.36
The effects of mental health parity on spending and utilization for bipolar, major depression, and adjustment disorders. Am J Psychiatry (2013) 1.34
Cost-sharing for emergency care and unfavorable clinical events: findings from the safety and financial ramifications of ED copayments study. Health Serv Res (2006) 1.34
Impact of full mental health and substance abuse parity for children in the Federal Employees Health Benefits Program. Pediatrics (2007) 1.33
New risk-adjustment system was associated with reduced favorable selection in medicare advantage. Health Aff (Millwood) (2012) 1.33
Antipsychotic and benzodiazepine use among nursing home residents: findings from the 2004 National Nursing Home Survey. Am J Geriatr Psychiatry (2010) 1.32
Hypertension treatment in a medicare population: adherence and systolic blood pressure control. Clin Ther (2007) 1.31
Reasons for choice of referral physician among primary care and specialist physicians. J Gen Intern Med (2011) 1.31
NIH state-of-the-science conference statement: Enhancing use and quality of colorectal cancer screening. NIH Consens State Sci Statements (2010) 1.30
Geographic correlation between large-firm commercial spending and Medicare spending. Am J Manag Care (2010) 1.30
Reasons for underuse of recommended therapies for colorectal and lung cancer in the Veterans Health Administration. Cancer (2011) 1.30
Comparative effectiveness of ST-segment-elevation myocardial infarction regionalization strategies. Circ Cardiovasc Qual Outcomes (2010) 1.28
Fixing flaws in Medicare drug coverage that prompt insurers to avoid low-income patients. Health Aff (Millwood) (2010) 1.27
Changes in drug utilization during a gap in insurance coverage: an examination of the medicare Part D coverage gap. PLoS Med (2011) 1.26
Economic burden of childhood autism spectrum disorders. Pediatrics (2014) 1.26
Racial and ethnic disparities among enrollees in Medicare Advantage plans. N Engl J Med (2014) 1.24
How the Medicare Part D drug benefit changed the distribution of out-of-pocket pharmacy spending among older beneficiaries. J Gerontol B Psychol Sci Soc Sci (2009) 1.23
The new medicare drug benefit: formularies and their potential effects on access to medications. J Gen Intern Med (2005) 1.22
How the new medicare drug benefit could affect vulnerable populations. Health Aff (Millwood) (2006) 1.21